iShares國防工業主動型ETF IDEF 深 滬
等待開盤 06-25 09:30:00 美东时间
31.12
-0.390
-1.24%
華盛通- 最 高31.40
- 今 開31.34
- 成交量 75.52万股
- 最 低 31.06
- 昨 收 31.51
- 總市值 393.23万
- 52周最高 36.8258
- 市盈率 靜 --
- 換手率 597.63%
- 52周最低 27.7935
- 委 比 -48.24%
- 總股本 0.00亿
- 歷史最高 36.8258
- 量 比 0.82
- 振 幅 1.08%
- 歷史最低 24.8635
- 每 手 1
- 風險率 2.45%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多U.S. Launches Retaliatory Strikes Against Iran — Defense Stocks, ETFs On Watch
U.S. retaliates against Iran with self-defense strikes after Apache helicopter downing. Defense stocks moving in after-hours trading.
06-10 06:12
Lockheed Martin Expands Defense Manufacturing Capacity In Alabama
Lockheed Martin (LMT) shares rise after breaking ground on a new Alabama munitions facility to expand THAAD interceptor production.
05-22 20:07
BRIEF-Serb Pharmaceuticals To Acquire European And MENA Rights To Idefirix From Hansa Biopharma
BRIEF-Serb Pharmaceuticals To Acquire European And MENA Rights To Idefirix From Hansa Biopharma May 19 (Reuters) - SERB Pharmaceuticals: SERB PHARMACEUTICALS TO ACQUIRE EUROPEAN AND MENA RIGHTS TO IDEFIRIX® (IMLIFIDASE) FROM HANSA BIOPHARMA FOR €115 MILLION Source text: ID:nGNX7zcJr6 Further company
05-19 13:37
Lockheed Martin Wins Space Force Interceptor Deal, Eyes 2028 Milestone
Lockheed Martin shares edge higher after securing a U.S. Space Force contract for its Space-Based Interceptor program, though weak momentum and a bearish technical setup keep near-term outlook mixed.
05-03 02:45
Hansa Biopharma Q1 operating loss widens to 142.5 MSEK; revenue falls to 34.6 MSEK
Hansa Biopharma Q1 operating loss widens to 142.5 MSEK; revenue falls to 34.6 MSEK Hansa Biopharma posted Q1 net loss of SEK 196.3 million, widening from SEK 38.8 million a year earlier. Revenue fell 47.8% to SEK 34.6 million. Operating loss widened to SEK 142.5 million from SEK 93.4 million. IDEFIR
04-23 13:02
美股盘后 | 瑞穗金融涨2.77%，罗克韦尔自动化涨2.66%
瑞穗金融涨2.77%；罗克韦尔自动化涨2.66%；Ares Management Corporation涨2.48%
04-01 06:10
